What banks are doing
Santander, BBVA and Deutsche Bank are organizing investor deals that shift default risk off their books, according to people familiar with the talks who asked not to be named because the transactions are private. Spokespeople for the three banks did not provide comment.
These instruments, known as synthetic risk transfers, typically insure a slice of a loan portfolio - roughly 5% to 15% - and it is usually the lowest-ranking piece that is covered. If credit quality worsens, investors backing that protection face losses.
The big-ticket deals and portfolios
Santander has five separate efforts underway. One is nearly wrapped up at its UK arm, covering around £1.4 billion in commercial real estate and project finance - about £400 million larger than the size first floated. Separately, it is putting together unfunded cover on about €3 billion of Spanish home loans, and is also eyeing a deal referencing corporate credit booked by its Portugal-based subsidiary. In Latin America, the bank is assembling a transaction referencing around 12 billion reais ($2.3 billion) in lending to Brazilian small and mid-sized firms, while also considering a deal connected to Mexico.
BBVA is putting together an SRT referencing about €5 billion in large corporate lending - near $5.8 billion - with the risk transfer sized at around 5% of the underlying portfolio. It has also begun early conversations for a separate deal involving smaller enterprises.
A steady, deliberate approach can help protect and grow your long term savings. Join Briefs Finance CEO Jaspreet Singh on September 29th for a FREE live investor workshop, How to Profit From A Dollar That's Losing its Value, where he shows how we're spotting investment opportunities as the dollar falls. Save your spot.
Deutsche Bank has initiated the planned sale of an SRT aimed at hedging around $4 billion of large corporate loans. Terms for all of these transactions could shift as investor discussions continue.
Why investors are interested and what it means for your money
Banks are sprinting to lock in capital relief before year-end, and investors have been drawn to the payout profiles. One example: Manulife CQS Investment Management is aiming for an internal rate of return near 13% on the fourth edition of its regulatory capital relief fund.
The pool of capital chasing this trade keeps expanding. BNP Paribas Asset Management recently secured a $600 million allocation from the Arizona State Retirement System to invest in SRTs, and the Abu Dhabi Investment Authority committed support for a fund run by Christofferson Robb & Co. In July, Crescent Capital Group LP projected that lenders in Europe and North America are on pace for a record roughly $45 billion of SRT issuance this year, compared with about $41 billion in 2025, and noted first-half sales topped $18 billion.
One caveat as deals proliferate: higher interest costs, supply chain jolts and uncertainty around artificial intelligence may lead buyers to tighten terms. For everyday investors, the takeaway is simple - more SRTs are coming to market with strong demand, but pricing and protections will reflect how cautious investors feel right now.
Keeping risk in focus lets you aim for growth while guarding your capital. Our CEO Jaspreet Singh is hosting a FREE live investor workshop, How to Profit From A Dollar That's Losing its Value, on September 29th. Sign up free to join him live.
